Nicola Crucinio
University of Foggia
Internal medicineUrologySurgeryOncologyRetrospective cohort studyLiver cancerSurvival ratePerformance statusRadiofrequency ablationLymphocyteHepatocellular carcinomaPercutaneousMonocyteMultivariate analysisConfidence intervalProportional hazards modelColorectal cancerMedicineCohortGastroenterology
9Publications
6H-index
149Citations
Publications 9
Newest
#1Antonio Facciorusso (University of Foggia)H-Index: 19
#2Valentina Del Prete (University of Foggia)H-Index: 13
Last. Michele Barone (University of Foggia)H-Index: 31
view all 5 authors...
Vitamin D is implicated in the etiology of several neoplastic diseases, but its relationship with colorectal cancer survival is still unclear. Aim of this study was to determine whether vitamin D levels influence survival outcomes in colorectal cancer liver metastases patients treated with percutaneous radiofrequency ablation.We measured 25-hydroxyvitamin D levels in 143 patients with 215 colorectal liver metastases who underwent radiofrequency ablation between 1999 and 2011 at our institution. ...
15 CitationsSource
#1Antonio Facciorusso (University of Foggia)H-Index: 19
#2Valentina Del Prete (University of Foggia)H-Index: 13
Last. Nicola Muscatiello (University of Foggia)H-Index: 22
view all 6 authors...
Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases
15 CitationsSource
Source
#1Antonio FacciorussoH-Index: 19
#2Valentina Del PreteH-Index: 13
Last. Gianluigi VendemialeH-Index: 21
view all 6 authors...
#1Antonio Facciorusso (University of Foggia)H-Index: 19
#2Valentina Del Prete (University of Foggia)H-Index: 13
Last. Michele Barone (University of Bari)H-Index: 31
view all 7 authors...
Background and Aim Inhibition of angiotensin II synthesis seems to decrease hepatocellular carcinoma recurrence after radical therapies; however, data on the adjuvant role of angiotensin II receptor 1 blockers (sartans) are still lacking. The aim of the study was to evaluate whether sartans delay time to recurrence and prolong overall survival in hepatocellular carcinoma patients after radiofrequency ablation. Methods Data on 153 patients were reviewed. The study population was classified into t...
32 CitationsSource
#1Antonio Facciorusso (University of Foggia)H-Index: 19
#2Valentina Del Prete (University of Foggia)H-Index: 13
Last. Michele Barone (University of Foggia)H-Index: 31
view all 8 authors...
Aim Survival estimates are commonly reported as survival from the first observation, but future survival probability changes based on the survival time already accumulated after therapy, otherwise known as conditional survival (CS). The aim of the study was to describe CS according to different prognostic variables in hepatocellular carcinoma (HCC) patients treated with radiofrequency ablation (RFA). Methods Data on 125 very early/early HCC patients treated with RFA between 1999 and 2007 were an...
17 CitationsSource
#1Antonio Facciorusso (University of Foggia)H-Index: 19
#2V. Del Prete (University of Foggia)H-Index: 1
Last. Michele Barone (University of Foggia)H-Index: 31
view all 5 authors...
1 CitationsSource
#1Antonio Facciorusso (University of Foggia)H-Index: 20
#2Valentina Del Prete (University of Foggia)H-Index: 13
Last. Michele Barone (University of Foggia)H-Index: 31
view all 8 authors...
Background and Aim Hepatic iron accumulation is considered to be a cofactor that influences liver injury and hepatocarcinogenesis. Aim of this study is to determine whether serum ferritin (SF) levels relate to overall survival (OS) and time to recurrence (TTR) in hepatocellular carcinoma (HCC) patients treated with percutaneous radiofrequency ablation (RFA). Methods We measured SF levels in 103 HCC patients (median age 70, M/F = 82.5%/17.5%) who underwent RFA between 2005 and 2010. Correlation b...
46 CitationsSource
#1Antonio Facciorusso (University of Foggia)H-Index: 19
#2Valentina Del Prete (University of Foggia)H-Index: 13
Last. Michele Barone (University of Foggia)H-Index: 31
view all 8 authors...
a b s t r a c t Background: Overall survival in hepatocellular carcinoma patients treated with percutaneous radiofre- quency ablation is influenced by both recurrence and successive treatments. We investigated post-recurrence survival after radiofrequency ablation. Methods: Data on 103 early/intermediate patients initially treated with radiofrequency ablation and fol- lowed for a median of 78 months (range 68-82) were retrospectively analysed. If intrahepatic disease recurrence occurred within o...
32 CitationsSource